The study emphasizes the necessity of further research concerning a treatment that is increasingly being legalized and applied to a wide range of medical conditions.
Cytokine markers IL-6 and IL-12 appeared to be sensitive to acute psychosocial stress in a laboratory setting.
The efficacy of melatonin, which has shown a prophylactic antidepressant effect in breast cancer, was explored given the prevalence of depressive symptoms after ACS.
Researchers examined the role of subcallosal cingulate deep brain stimulation in treatment-resistant depression.
Researchers assessed the total effect of bipolar disorder and major depression on cognitive function in adults between 40 and 69 years old and measured the effects mediated by psychotropic drug use and cardiometabolic disease.
Lithium use was associated with lower intensity of depressive symptoms, reduced clinical severity, and lower benzodiazepine use.
Antidepressants strongly inhibiting serotonin reuptake may be associated with a small reduction in the rate of ischemic stroke compared with weak reuptake inhibitors.
Anticonvulsant mood stabilizers were not linked to a greater risk for placenta-mediated complications or preterm birth.
Ten of 18 reviewed treatment strategies linked to higher response versus sham therapy
Consistent with primary KINECT 3 study results, supplemental analyses indicate that participants treated with valbenazine had statistically significant improvements in tardive dyskinesia severity.